Indeed, p53 deficiency, in association with activating mutations of oncogenes, such as RAS and BRAF, accounts for the high proliferation rate and increased aggressiveness of the more aggressive forms of thyroid cancer [73]. Here, BRAF is linked to thyroid gland carcinoma.